Defilade Capital Management »

Ascendis Pharma A S shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 52k 228.73

More positions owned by Defilade Capital Management

Zimmer Holdings (ZBH)
Henry Schein (HSIC)
Becton, Dickinson and (BDX)
Pfizer (PFE)
Dex (DXCM)
ICU Medical, Incorporated (ICUI)
Insmed Com Par $.01 (INSM)
Intuitive Surgical Com New (ISRG)
Revolution Medicines (RVMD)
Globus Med Cl A (GMED)
Neurocrine Biosciences (NBIX)
Denali Therapeutics (DNLI)
Ptc Therapeutics I (PTCT)
Olema Pharmaceuticals (OLMA)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Ascendis Pharma A S

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
FMR
Artisan Partners Limited Partnership
Franklin Resources
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Wellington Management Company
T. Rowe Price Investment Management
Perceptive Advisors
American Century Companies
Capital World Investors
Principal Financial Group
Ameriprise Financial

View all funds holding Ascendis Pharma A S